Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

The crystal structure of the hemagglutinin of both the viruses is similar, especially within the Sa antigenic site. Compared with seasonal influenza outbreaks, the overall impact of the 2009 H1N1 ...

The spread of H5N1 avian influenza virus in the United States has sparked fears of a potential pandemic. The H5N1 virus is ...

Scientists at the United States Department of Agriculture's National Animal Disease Center, with multiple academic, state and ...

While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...

While current influenza vaccines primarily target the variable hemagglutinin protein, the slower-evolving neuraminidase presents a promising target for the development of new vaccines providing ...

Infectimune® studies funded by and performed by investigators at the National Institute of Allergy and Infectious Diseases (NIAID)’s Center for Influenza Vaccine Research for High-Risk Populations ...

Influenza A viruses are divided into subtypes based on characteristics of two major surface proteins, hemagglutinin (HA) and neuraminidase (NA) – as in, for example, the strain annually ...